Article Details
Retrieved on: 2024-08-08 13:24:39
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The panel of independent experts known as STIKO said in a statement that one shot, either Pfizer's Abrysvo or Arexvy by GSK, should be ...
Article found on: www.marketscreener.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here